These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 9201554
1. Effects of the angiotensin AT1 receptor antagonist GRI38950 on haemodynamic function in dogs. Hunt AA, Hilditch A, Drew GM. J Auton Pharmacol; 1997 Feb; 17(1):1-11. PubMed ID: 9201554 [Abstract] [Full Text] [Related]
2. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist. Hilditch A, Hunt AA, Travers A, Polley J, Drew GM, Middlemiss D, Judd DB, Ross BC, Robertson MJ. J Pharmacol Exp Ther; 1995 Feb; 272(2):750-7. PubMed ID: 7853190 [Abstract] [Full Text] [Related]
3. Further investigations into the mechanism of the antihypertensive activity of the angiotensin AT1 receptor antagonist, GR138950. Hilditch A, Prior HM, Drew GM. Br J Pharmacol; 1996 Jun; 118(3):711-9. PubMed ID: 8762098 [Abstract] [Full Text] [Related]
4. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats. Anderson IK, Drew GM. Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652 [Abstract] [Full Text] [Related]
5. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. Anderson IK, Drew GM. Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286 [Abstract] [Full Text] [Related]
6. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist. Hilditch A, Hunt AA, Gardner CJ, Twissell DJ, Polley J, Travers A, Drew GM, Middlemiss D, Ross BC, Robertson MJ. Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689 [Abstract] [Full Text] [Related]
7. Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation. Forhead AJ, Whybrew K, Hughes P, Broughton Pipkin F, Sutherland M, Fowden AL. Br J Pharmacol; 1996 Sep; 119(2):393-401. PubMed ID: 8886426 [Abstract] [Full Text] [Related]
8. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns. Clair MJ, Krombach RS, Hendrick JW, Houck WV, Hebbar L, Kribbs SB, Rios G, Whitebread S, Mukherjee R, de Gasparo M, Spinale FG. J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853 [Abstract] [Full Text] [Related]
10. Role of AT2 receptors in the cardiovascular events following microinjection of angiotensin II into the superior colliculus of anaesthetised rats. D'Amico M, Di Filippo C, Rossi F, Warner TD. Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb 04; 357(2):121-5. PubMed ID: 9521484 [Abstract] [Full Text] [Related]
11. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs. Hayashi N, Yamamoto S, Kometani M, Nakao K. Arzneimittelforschung; 1997 May 04; 47(5):620-5. PubMed ID: 9205775 [Abstract] [Full Text] [Related]
12. The role of angiotensin II AT1 receptor in the maintenance of hemodynamics in a canine model of coronary microembolization-induced heart failure. Wang J, Yi GH, Zhu SM, Gu AG, Popilskis S, Zhang H, Burkhoff D. J Cardiovasc Pharmacol; 1999 Feb 04; 33(2):335-40. PubMed ID: 10028945 [Abstract] [Full Text] [Related]
13. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Gardiner SM, Kemp PA, March JE, Bennett T. Br J Pharmacol; 1995 Jun 04; 115(4):579-86. PubMed ID: 7582475 [Abstract] [Full Text] [Related]
14. Role of AT1 receptors in the central control of sympathetic vasomotor function. Head GA. Clin Exp Pharmacol Physiol Suppl; 1996 Jun 04; 3():S93-8. PubMed ID: 8993846 [Abstract] [Full Text] [Related]
15. A comparison of the cardiovascular effects of sodium nitroprusside and trimethaphan. Wang HH, Liu LM, Katz RL. Anesthesiology; 1977 Jan 04; 46(1):40-8. PubMed ID: 831593 [Abstract] [Full Text] [Related]
16. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat. Nekooeian AA, Tabrizchi R. Br J Pharmacol; 1998 Apr 04; 123(8):1666-72. PubMed ID: 9605574 [Abstract] [Full Text] [Related]
17. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. Li JS, Sharifi AM, Schiffrin EL. J Cardiovasc Pharmacol; 1997 Jul 04; 30(1):75-83. PubMed ID: 9268224 [Abstract] [Full Text] [Related]
18. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs. Pagel PS, Harkin CP, Hettrick DA, Warltier DC. Anesthesiology; 1994 Oct 04; 81(4):974-87. PubMed ID: 7943849 [Abstract] [Full Text] [Related]
19. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. Pagel PS, Proctor LT, Devcic A, Hettrick DA, Kersten JR, Tessmer JP, Farber NE, Schmeling WT, Warltier DC. J Cardiothorac Vasc Anesth; 1998 Aug 04; 12(4):429-34. PubMed ID: 9713732 [Abstract] [Full Text] [Related]
20. Prolonged systemic and regional haemodynamic effects of intracerebroventricular angiotensin II in conscious sheep. May CN. Clin Exp Pharmacol Physiol; 1996 Aug 04; 23(10-11):878-84. PubMed ID: 8911729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]